Mabion S.A. (WSE:MAB)

Poland flag Poland · Delayed Price · Currency is PLN
8.26
+0.01 (0.12%)
Jan 28, 2026, 5:00 PM CET
-3.95%
Market Cap133.34M
Revenue (ttm)14.81M -86.6%
Net Income-59.30M
EPS-3.68
Shares Out16.16M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,932
Average Volume50,716
Open8.24
Previous Close8.25
Day's Range8.20 - 8.31
52-Week Range6.70 - 11.80
Beta0.43
RSI60.81
Earnings DateApr 23, 2026

About Mabion

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services. In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation o... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 213
Stock Exchange Warsaw Stock Exchange
Ticker Symbol MAB
Full Company Profile

Financial Performance

Financial Statements